Class information for:
Level 1: CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//TRIPLE ANTIPLATELET THERAPY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
17435 599 31.6 83%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
8 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1276458
131 3       HEMATOLOGY//HAEMOPHILIA//TRANSFUSION 66936
966 2             CLOPIDOGREL//PRASUGREL//TICAGRELOR 10690
17435 1                   CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//TRIPLE ANTIPLATELET THERAPY 599

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CILOSTAZOL authKW 9563557 53% 59% 318
2 CLIN PHARMACOKINET PHARMACODYNAM METAB address 375366 2% 82% 9
3 TRIPLE ANTIPLATELET THERAPY authKW 275263 2% 60% 9
4 CAS 73963 72 1 authKW 163122 1% 80% 4
5 PHOSPHODIESTERASE 3 INHIBITOR authKW 152916 2% 33% 9
6 MED I EM TISSUE REGENERAT address 137654 3% 16% 17
7 OPC 13013 authKW 114695 1% 75% 3
8 PLETAALR authKW 101952 0% 100% 2
9 CILOSTAZOL CLINICAL STUDIES authKW 67967 0% 67% 2
10 K 134 authKW 67967 0% 67% 2

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Peripheral Vascular Diseases 3169 22% 0% 130
2 Pharmacology & Pharmacy 1781 33% 0% 197
3 Cardiac & Cardiovascular System 1760 22% 0% 132
4 Hematology 239 7% 0% 41
5 Chemistry, Medicinal 156 6% 0% 33
6 Neurosciences 104 10% 0% 61
7 Medicine, Research & Experimental 75 5% 0% 32
8 Surgery 57 8% 0% 45
9 Endocrinology & Metabolism 47 5% 0% 28
10 Clinical Neurology 44 5% 0% 32

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CLIN PHARMACOKINET PHARMACODYNAM METAB 375366 2% 82% 9
2 MED I EM TISSUE REGENERAT 137654 3% 16% 17
3 NEW DRUG DISCOVERY 1 65721 1% 18% 7
4 ADV PHARMACOL 65537 1% 43% 3
5 MERIDIAN STRUCT MED 53641 2% 11% 10
6 ANAESTHESIA REANIMATON 50976 0% 100% 1
7 BEIJING HEART LUNG BLOOD VESSEL 50976 0% 100% 1
8 BEIJING MIL BRANCH 50976 0% 100% 1
9 BEIJING PEDIAT ORGAN FAILURE 50976 0% 100% 1
10 BIOFUCT MOL 50976 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 5090 4% 0% 21
2 ATHEROSCLEROSIS SUPPLEMENTS 4591 1% 2% 5
3 CIRCULATION JOURNAL 3978 3% 0% 19
4 JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS 2910 1% 1% 8
5 CARDIOVASCULAR THERAPEUTICS 1809 1% 1% 4
6 CLINICAL PHARMACOKINETICS 1739 2% 0% 9
7 THROMBOSIS RESEARCH 1251 3% 0% 16
8 JOURNAL OF GERIATRIC CARDIOLOGY 1094 1% 1% 3
9 ATHEROSCLEROSIS 920 2% 0% 14
10 JOURNAL OF STROKE & CEREBROVASCULAR DISEASES 776 1% 0% 6

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CILOSTAZOL 9563557 53% 59% 318 Search CILOSTAZOL Search CILOSTAZOL
2 TRIPLE ANTIPLATELET THERAPY 275263 2% 60% 9 Search TRIPLE+ANTIPLATELET+THERAPY Search TRIPLE+ANTIPLATELET+THERAPY
3 CAS 73963 72 1 163122 1% 80% 4 Search CAS+73963+72+1 Search CAS+73963+72+1
4 PHOSPHODIESTERASE 3 INHIBITOR 152916 2% 33% 9 Search PHOSPHODIESTERASE+3+INHIBITOR Search PHOSPHODIESTERASE+3+INHIBITOR
5 OPC 13013 114695 1% 75% 3 Search OPC+13013 Search OPC+13013
6 PLETAALR 101952 0% 100% 2 Search PLETAALR Search PLETAALR
7 CILOSTAZOL CLINICAL STUDIES 67967 0% 67% 2 Search CILOSTAZOL+CLINICAL+STUDIES Search CILOSTAZOL+CLINICAL+STUDIES
8 K 134 67967 0% 67% 2 Search K+134 Search K+134
9 PERIPHERAL ARTERIAL OCCLUSION DISEASE PAOD 67967 0% 67% 2 Search PERIPHERAL+ARTERIAL+OCCLUSION+DISEASE+PAOD Search PERIPHERAL+ARTERIAL+OCCLUSION+DISEASE+PAOD
10 PHOSPHODIESTERASE III INHIBITOR 55495 1% 16% 7 Search PHOSPHODIESTERASE+III+INHIBITOR Search PHOSPHODIESTERASE+III+INHIBITOR

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 KAMBAYASHI, J , LIU, YG , SUN, B , SHAKUR, Y , YOSHITAKE, M , CZERWIEC, F , (2003) CILOSTAZOL AS A UNIQUE ANTITHROMBOTIC AGENT.CURRENT PHARMACEUTICAL DESIGN. VOL. 9. ISSUE 28. P. 2289-2302 75 57% 110
2 LIU, YG , SHAKUR, Y , YOSHITAKE, M , KAMBAYASHI, J , (2001) CILOSTAZOL (PLETAL (R)): A DUAL INHIBITOR OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE TYPE 3 AND ADENOSINE UPTAKE.CARDIOVASCULAR DRUG REVIEWS. VOL. 19. ISSUE 4. P. 369-386 45 64% 98
3 DALAINAS, I , (2007) CILOSTAZOL IN THE MANAGEMENT OF VASCULAR DISEASE.INTERNATIONAL ANGIOLOGY. VOL. 26. ISSUE 1. P. 1 -7 36 68% 8
4 ROGERS, KC , OLIPHANT, CS , FINKS, SW , (2015) CLINICAL EFFICACY AND SAFETY OF CILOSTAZOL: A CRITICAL REVIEW OF THE LITERATURE.DRUGS. VOL. 75. ISSUE 4. P. 377 -395 36 50% 5
5 BISCETTI, F , FERRACCIOLI, G , FLEX, A , (2015) NEW THERAPEUTIC EFFECTS OF CILOSTAZOL IN PATIENTS WITH ISCHEMIC DISORDERS.CURRENT VASCULAR PHARMACOLOGY. VOL. 13. ISSUE 3. P. 399 -404 28 62% 4
6 BIONDI-ZOCCAI, GGL , LOTRIONTE, M , ANSELMINO, M , MORETTI, C , AGOSTONI, P , TESTA, L , ABBATE, A , COSGRAVE, J , LAUDITO, A , TREVI, GP , ET AL (2008) SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS APPRAISING THE IMPACT OF CILOSTAZOL AFTER PERCUTANEOUS CORONARY INTERVENTION.AMERICAN HEART JOURNAL. VOL. 155. ISSUE 6. P. 1081-1089 25 71% 67
7 CHEN, J , MENG, HY , XU, L , LIU, J , KONG, DY , CHEN, PS , GONG, XX , BAI, JL , ZOU, FW , YANG, ZJ , ET AL (2015) EFFICACY AND SAFETY OF CILOSTAZOL BASED TRIPLE ANTIPLATELET TREATMENT VERSUS DUAL ANTIPLATELET TREATMENT IN PATIENTS UNDERGOING CORONARY STENT IMPLANTATION: AN UPDATED META-ANALYSIS OF THE RANDOMIZED CONTROLLED TRIALS.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 39. ISSUE 1. P. 23 -34 23 61% 10
8 TAMHANE, U , MEIER, P , CHETCUTI, S , CHEN, KY , RHA, SW , GROSSMAN, MP , GURM, H , (2009) EFFICACY OF CILOSTAZOL IN REDUCING RESTENOSIS IN PATIENTS UNDERGOING CONTEMPORARY STENT BASED PCI: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS.EUROINTERVENTION. VOL. 5. ISSUE 3. P. 384-393 26 60% 47
9 GENG, DF , DENG, J , JIN, DM , WU, W , WANG, JF , (2012) EFFECT OF CILOSTAZOL ON THE PROGRESSION OF CAROTID INTIMA-MEDIA THICKNESS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS.ATHEROSCLEROSIS. VOL. 220. ISSUE 1. P. 177 -183 22 69% 13
10 FUKUOKA, T , HAYASHI, T , HIRAYAMA, M , MARUYAMA, H , TANAHASHI, N , (2014) CILOSTAZOL INHIBITS LEUKOCYTE-ENDOTHELIAL CELL INTERACTIONS IN MURINE MICROVESSELS AFTER TRANSIENT BILATERAL COMMON CAROTID ARTERY OCCLUSION.BRAIN RESEARCH. VOL. 1543. ISSUE . P. 173-178 23 66% 1

Classes with closest relation at Level 1


Rank Class id link
1 37587 IBUDILAST//CAS 50847 11 5//3 ISOBUTYRYL 2 ISOPROPYLPYRAZOLO1 5 APYRIDINE PHARMACOLOGY
2 22615 PROBUCOL//AGI 1067//SUCCINOBUCOL
3 504 PERIPHERAL ARTERIAL DISEASE//ANKLE BRACHIAL INDEX//INTERMITTENT CLAUDICATION
4 310 CLOPIDOGREL//PRASUGREL//TICAGRELOR
5 22264 CHRONIC CEREBRAL HYPOPERFUSION//2 3 5 TRIPHENYLTERAZOLIUM CHLORIDE STAINING//CNS CVS PHARMACOL
6 17743 TICLOPIDINE//TICLOPIDINE HYDROCHLORIDE//E5510
7 23565 VESNARINONE//TSC 22//POSITIVE INOTROPIC ACTIVITY
8 25152 DIPYRIDAMOLE//VASODILATOR DRUG//MOPIDAMOL
9 23008 PARTICLE COUNTING METHOD//WHOLE BLOOD PLATELET AGGREGATION//SPONTANEOUS PLATELET AGGREGATION
10 658 ROLIPRAM//PHOSPHODIESTERASE//PDE4

Go to start page